Filing Details

Accession Number:
0001099219-21-000077
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-26 16:31:02
Reporting Period:
2021-02-24
Accepted Time:
2021-02-26 16:31:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099219 Metlife Inc MET Life Insurance (6311) 134075851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709116 D. John Mccallion Metlife, Inc.
200 Park Avenue
New York NY 10166
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-24 10,745 $34.21 77,178 No 4 M Direct
Common Stock Disposition 2021-02-24 7,742 $59.52 69,436 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2021-02-24 10,745 $0.00 10,745 $34.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-02-27 No 4 M Direct
Footnotes
  1. Sale to pay option exercise price and related tax obligations and fees.
  2. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices $59.515 to $59.52, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
  3. The options became exercisable in three substantially equal installments on February 28, 2013, 2014 and 2015.